X Prize Foundation

NEW YORK (GenomeWeb News) – The X Prize Foundation has decided to cancel the Archon Genomics X Prize, saying that the plummeting cost of sequencing a genome had rendered the competition moot.

The Archon Genomics X Prize, backed by a new sponsor, has revised the guidelines for the competition to reflect its interest in attaining a "medical grade genome," the X Prize Foundation said this week.

Earlier this month, the X Prize Foundation appointed Grant Campany as senior director for the Archon Genomics X Prize. The prize offers a $10 million cash award to the first team to sequence 100 human genomes in 10 days or less for a maximum of $1 million in total costs.

Cracker becomes the first Asia-based contender for the $10 million prize and eighth contender overall.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.